Medeon Biodesign, Inc. researches, develops, manufactures, and sells medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is involved in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. The company was incorporated in 2012 and is based in Taipei, Taiwan.
Metrics to compare | 6499 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6499PeersSector | |
---|---|---|---|---|
P/E Ratio | −12.4x | 0.0x | −0.6x | |
PEG Ratio | −1.59 | 0.00 | 0.00 | |
Price/Book | 8.4x | 0.0x | 2.6x | |
Price / LTM Sales | 23.6x | 0.0x | 3.3x | |
Upside (Analyst Target) | 43.6% | 0.0% | 38.7% | |
Fair Value Upside | Unlock | 0.0% | 5.1% | Unlock |